Skip to content
- US FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults with Advanced Parkinson’s DiseaseAbVie
- FDA Approves AbbVie’s Parkinson’s Treatment, Medicare Coverage Expected Next YearYahoo Finance
- Third time’s the charm: AbbVie scores FDA nod for continued treatment of Parkinson’s disease VyalevFiercePharma
- AbbVie receives FDA approval for Vyalev in adults with advanced Parkinson’s diseaseMarketWatch
- FDA Approves Foscarbidopa/Foslevodopa for Motor Fluctuations in Adults with Parkinson’s DiseasePharmacy times
